Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
AEON Biopharma, Inc. (AEON) Insider Trading Activity
Healthcare • Biotechnology • 5 employees
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and posttraumatic stress disorder. The company is based in Irvine, California.
Total Value
$30,000.00
Total Shares
1,005,013
Average Trade Value
$3,750.00
Most Active Insider
Carter Eric G
Total Activity: $10,000
Largest Single Transaction
$10,000
by Carter Eric G on Aug 31, 2024
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
---|---|---|---|---|---|---|
Exec Vp, Clo Corp Secretary
Officer
|
Aug 31, 2024 | 180,110 | $0 | 261,538 (+68.9%) | Grant | |
Director
|
Aug 31, 2024 | 36,021 | $0 | 96,785 (+37.2%) | Grant | |
Principal Accounting Officer
Officer
|
Aug 31, 2024 | 18,010 | $0 | 18,010 (+100.0%) | Grant | |
Chief Medical Officer
Officer
|
Aug 31, 2024 | 192,117 | $0 | 292,545 (+65.7%) | Grant | |
Director
|
Aug 31, 2024 | 36,021 | $10,000 | 36,021 (+100.0%) | Grant | |
Chief Exectuive Officer
Director, Officer
|
Aug 31, 2024 | 470,692 | $0 | 750,547 (+62.7%) | Grant | |
Director
|
Aug 31, 2024 | 36,021 | $10,000 | 36,021 (+100.0%) | Grant | |
Director
|
Aug 31, 2024 | 36,021 | $10,000 | 36,021 (+100.0%) | Grant |